G Travert

1.0k total citations
30 papers, 546 citations indexed

About

G Travert is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, G Travert has authored 30 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nutrition and Dietetics. Recurrent topics in G Travert's work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (13 papers) and Infant Nutrition and Health (6 papers). G Travert is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (13 papers) and Infant Nutrition and Health (6 papers). G Travert collaborates with scholars based in France, Netherlands and Italy. G Travert's co-authors include Kevin W Southern, Carlo Castellani, Luisa Zanolla, À. Munck, J.E. Dankert-Roelse, R. J. Pollitt, Marie-Christine Lebrethon, R. Leroyer, Jean Alain Chayvialle and J Mahoudeau and has published in prestigious journals such as New England Journal of Medicine, Clinical Chemistry and Human Genetics.

In The Last Decade

G Travert

28 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Travert France 9 273 186 153 58 53 30 546
M Messina Italy 11 66 0.2× 271 1.5× 127 0.8× 83 1.4× 103 1.9× 22 492
Emmanuel Economou Greece 12 70 0.3× 97 0.5× 54 0.4× 59 1.0× 77 1.5× 33 547
Poh‐Sim Low Singapore 11 69 0.3× 92 0.5× 149 1.0× 55 0.9× 39 0.7× 24 344
Randy Linde United States 9 58 0.2× 207 1.1× 101 0.7× 90 1.6× 40 0.8× 18 501
M. J. THOMSETT Australia 14 47 0.2× 412 2.2× 140 0.9× 89 1.5× 116 2.2× 28 536
Victoria Stokes United Kingdom 11 61 0.2× 143 0.8× 74 0.5× 57 1.0× 30 0.6× 21 358
J. Rodríguez‐Arnao United Kingdom 11 36 0.1× 368 2.0× 49 0.3× 76 1.3× 51 1.0× 13 479
Lars Østergaard Kristensen Denmark 15 35 0.1× 366 2.0× 94 0.6× 144 2.5× 57 1.1× 21 544
Mateusz Jagła Poland 10 177 0.6× 46 0.2× 52 0.3× 76 1.3× 35 0.7× 28 343
Gianluca Cosi Italy 5 179 0.7× 101 0.5× 101 0.7× 89 1.5× 44 0.8× 9 383

Countries citing papers authored by G Travert

Since Specialization
Citations

This map shows the geographic impact of G Travert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Travert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Travert more than expected).

Fields of papers citing papers by G Travert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Travert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Travert. The network helps show where G Travert may publish in the future.

Co-authorship network of co-authors of G Travert

This figure shows the co-authorship network connecting the top 25 collaborators of G Travert. A scholar is included among the top collaborators of G Travert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Travert. G Travert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Travert, G, et al.. (2020). History of Newborn Screening for Cystic Fibrosis—The Early Years. International Journal of Neonatal Screening. 6(1). 8–8. 17 indexed citations
2.
Southern, Kevin W, À. Munck, R. J. Pollitt, et al.. (2006). A survey of newborn screening for cystic fibrosis in Europe. Journal of Cystic Fibrosis. 6(1). 57–65. 178 indexed citations
3.
Farriaux, J. P., M Vidailhet, Marie‐Louise Briard, et al.. (2003). Le programme national de depistage neonatal de la mucoviscidose mise en place et organisation. Archives de Pédiatrie. 10. S364–S369. 6 indexed citations
4.
Brouard, J., et al.. (2001). Évaluation du diagnostic et du suivi de la cohorte normande d'enfants dépistés atteints de mucoviscidose. Archives de Pédiatrie. 8. 603–609. 7 indexed citations
5.
Wilcken, Bridget & G Travert. (1999). Neonatal screening for cystic fibrosis: present and future. Acta Paediatrica. 88(s432). 33–35. 20 indexed citations
6.
Mallet, E., et al.. (1996). The A985 to G mutation of the medium‐chain acyl‐CoA dehydrogenase gene and sudden infant death syndrome in Normandy. Acta Paediatrica. 85(2). 145–147. 6 indexed citations
8.
Verlingue, C., et al.. (1994). [Cystic fibrosis gene mutations in the West of France: clinical application].. PubMed. 52(11). 757–64. 3 indexed citations
9.
Reznik, Yves, Jean Alain Chayvialle, R. Leroyer, et al.. (1992). Food-Dependent Cushing's Syndrome Mediated by Aberrant Adrenal Sensitivity to Gastric Inhibitory Polypeptide. New England Journal of Medicine. 327(14). 981–986. 200 indexed citations
10.
Travert, G, et al.. (1992). Dépistage néonatal de la mucoviscidose : l'expérience de l'équipe de Caen. Immuno-analyse & Biologie Spécialisée. 7(3). 87–93. 1 indexed citations
11.
Lemonnier, François, et al.. (1992). Intérêt du dosage de la T4 et de la T3 libres dans le sang séché sur papier-filtre. Immuno-analyse & Biologie Spécialisée. 7(3). 67–70.
12.
Travert, G, et al.. (1991). The international quality assurance program (IRTIQAS) for the assay of immunoreactive trypsin in dried blood spots. Pediatric Pulmonology. 11(S7). 72–75. 7 indexed citations
13.
Laroche, D., et al.. (1991). Free thyroxin measured in dried blood spots from normal, low-birth-weight, and hypothyroid neonates. Clinical Chemistry. 37(12). 2114–2117. 5 indexed citations
14.
Lemonnier, François, et al.. (1991). Dosage de la T4 libre dans le sang séché sur papier filtre. Une aide au dépistage systématique des hypothyroïdies congénitales. Immuno-analyse & Biologie Spécialisée. 6(5). 59–63. 1 indexed citations
15.
Laroche, D., et al.. (1990). [A new strategy of neonatal screening for cystic fibrosis. The association of immunoreactive trypsin and molecular biology in dried blood].. PubMed. 47(4). 251–3. 1 indexed citations
16.
Laroche, D., et al.. (1989). Trypsin-Binding Immunoglobulin G and Associated Antigen in Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 9(1). 13–16. 2 indexed citations
17.
Laroche, D., et al.. (1989). Trypsin-Binding Immunoglobulin G and Associated Antigen in Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 9(1). 13–16. 2 indexed citations
18.
Laroche, Davy, et al.. (1988). Free triiodothyronine measured in dried blood spots from normal, low-birth-weight, and hypothyroid neonates.. Clinical Chemistry. 34(12). 2448–2451. 6 indexed citations
19.
Laroche, D., et al.. (1987). Amniotic immunoreactive trypsin in pregnancies with normal and pathological outcomes. Acta Obstetricia Et Gynecologica Scandinavica. 66(7). 587–590. 1 indexed citations
20.
Travert, G, et al.. (1983). Dépistage néonatal systématique de la mucoviscidose par dosage de la trypsine immunoréactive sanguine. Bilan de 80 000 tests.. 40(4). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026